Table 2.
Past 6 month receipt of alcohol treatment medications at baseline and follow-up by treatment group
| Medication, n (%) | Integrated stepped alcohol treatment (n = 47) | Treatment as usual (n = 46) | p value |
|---|---|---|---|
| Any alcohol treatment medicationa | |||
| Baseline | 5 (10.6) | 10 (21.7) | 0.15 |
| Week 24 | 8 (17.0) | 11 (23.9) | 0.41 |
| Week 52 | 5 (10.6) | 6 (13.0) | 0.72 |
| Disulfiram | |||
| Baseline | 0 (0) | 0 (0) | NA |
| Week 24 | 0 (0) | 0 (0) | NA |
| Week 52 | 0 (0) | 0 (0) | NA |
| Acamprosate | |||
| Baseline | 0 (0) | 0 (0) | NA |
| Week 24 | 0 (0) | 0 (0) | NA |
| Week 52 | 0 (0) | 0 (0) | NA |
| Naltrexone | |||
| Baseline | 0 (0) | 0 (0) | NA |
| Week 24 | 1 (2.1) | 1 (2.2) | 0.99 |
| Week 52 | 1 (2.1) | 0 (0) | 0.99 |
| Topiramate | |||
| Baseline | 0 (0) | 0 (0) | NA |
| Week 24 | 0 (0) | 0 (0) | NA |
| Week 52 | 0 (0) | 0 (0) | NA |
| Baclofen | |||
| Baseline | 1 (2.1) | 2 (4.4) | 0.62 |
| Week 24 | 2 (4.3) | 2 (4.4) | 0.99 |
| Week 52 | 2 (4.3) | 1 (2.2) | 0.99 |
| Gabapentin | |||
| Baseline | 4 (8.5) | 8 (17.4) | 0.20 |
| Week 24 | 6 (12.8) | 8 (17.4) | 0.53 |
| Week 52 | 4 (8.5) | 5 (10.9) | 0.74 |
aBased on receipt of disulfiram, acamprosate, naltrexone, topiramate, baclofen and/or gabapentin